☆ 4.7 Review

Antibiotic Treatment Duration for Community-Acquired Pneumonia in Outpatient Children in High-Income Countries-A Systematic Review and Meta-Analysis

CLINICAL INFECTIOUS DISEASES (2023)

Related references

Note: Only part of the references are listed.

Review Infectious Diseases

Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis

Jennifer Curran et al.

Summary: The study found that each additional day of antibiotic therapy is associated with measurable antibiotic harm, particularly adverse events. These data may provide additional context for clinicians when weighing benefits versus risks of prolonged antibiotic therapy.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Add to Collection

Article Pediatrics

Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children The SCOUT-CAP Randomized Clinical Trial

Derek J. Williams et al.

Summary: In a study among children with outpatient CAP, a 5-day antibiotic strategy was found to be superior to a 10-day strategy, resulting in similar clinical response and antibiotic-associated adverse effects, while reducing antibiotic exposure and resistance.

JAMA PEDIATRICS (2022)

Add to Collection

Article Mathematical & Computational Biology

Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments

Luke A. McGuinness et al.

Summary: Despite the availability of numerous software options for evidence synthesis, there is currently no universal tool for generating figures to display and explore risk-of-bias assessments. However, tools such as the R programming environment and Shiny have made it easy to create new tools for producing evidence syntheses. The new tool robvis facilitates the rapid production of publication-quality risk-of-bias assessment figures and is available as an R package and web app.

RESEARCH SYNTHESIS METHODS (2021)

Add to Collection

Review Infectious Diseases

Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis

Kristin Andrejko et al.

Summary: This study reviewed antimicrobial susceptibility studies of pediatric pneumococcal isolates from 2000 to 2020, finding significant reductions in non-susceptibility of pneumococci to penicillin, sulfamethoxazole-trimethoprim, and third-generation cephalosporins after implementation of PCV products. The findings suggest that PCV implementation has led to decreased resistance of pneumococci to first-line antibiotic treatments for pneumonia.

LANCET MICROBE (2021)

Add to Collection

Article Medicine, General & Internal

Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia The CAP-IT Randomized Clinical Trial

Julia A. Bielicki et al.

Summary: In a clinical trial involving 814 children with community-acquired pneumonia, it was found that lower-dose oral amoxicillin (35-50 mg/kg/day) was noninferior to higher dose (70-90 mg/kg/day), and a 3-day regimen was noninferior to 7 days in terms of the need for antibiotic re-treatment. However, various factors such as disease severity, treatment setting, prior antibiotics received, and acceptability of the noninferiority margin need to be considered when interpreting the findings.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Pediatrics

Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia The SAFER Randomized Clinical Trial

Jeffrey M. Pernica et al.

Summary: In previously healthy children with community-acquired pneumonia not requiring hospitalization, short-course antibiotic therapy appeared to be comparable to standard care.

JAMA PEDIATRICS (2021)

Add to Collection

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Review Pediatrics

Antibiotic therapy in children with community-acquired pneumonia

Matti Korppi

Summary: The review of PubMed on antibiotic treatment of community-acquired pneumonia (CAP) in children for the years 2011-2020 found that five-day courses were equally effective as longer courses. No new antibiotics were launched for children's CAP during the last 10 years, and stewardship of antibiotics needs lessening of exposure to antibiotics and shortening the lengths of antibiotic courses.

ACTA PAEDIATRICA (2021)

Add to Collection

Article Medicine, General & Internal

Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial

Paul Little et al.

Summary: The study found that amoxicillin is unlikely to be clinically effective in reducing symptom duration in children with uncomplicated lower respiratory tract infections, overall or in key clinical subgroups where antibiotics are commonly prescribed. Unless pneumonia is suspected, clinicians should not prescribe antibiotics for most children presenting with chest infections.

LANCET (2021)

Add to Collection

Article Health Care Sciences & Services

Including Non-inferiority Trials in Contemporary Meta-analyses of Chronic Medical Conditions: a Meta-epidemiological Study

Zhen Wang et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2020)

Add to Collection

Article Health Care Sciences & Services

Meta-analysis of noninferiority and equivalence trials: ignoring trial design leads to differing and possibly misleading conclusions

Sergio A. Acuna et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children

Amy-Sarah Ginsburg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Complicated pneumonia in children

Fernando M de Benedictis et al.

LANCET (2020)

Add to Collection

Review Pediatrics

Finnish guidelines for the treatment of community-acquired pneumonia and pertussis in children

Terhi Tapiainen et al.

ACTA PAEDIATRICA (2016)

Add to Collection

Article Immunology

Short-course Antibiotic Treatment for Community-acquired Alveolar Pneumonia in Ambulatory Children A Double-blind, Randomized, Placebo-controlled Trial

David Greenberg et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)

Add to Collection

Article Pediatrics

Treatment of Mycoplasma Pneumonia: A Systematic Review

Eric Biondi et al.

PEDIATRICS (2014)

Add to Collection

Review Respiratory System

Evidence for short duration of antibiotic treatment for non-severe community acquired pneumonia (CAP) in children - are we there yet? A systematic review of randomised controlled trials

Shalom Ben-Shimol et al.

PNEUMONIA (2014)

Add to Collection

Article Immunology

Executive Summary: The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

John S. Bradley et al.

CLINICAL INFECTIOUS DISEASES (2011)

Add to Collection

Article Respiratory System

British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011

Michael Harris et al.

THORAX (2011)

Add to Collection

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Add to Collection

Review Pediatrics

Community-acquired pneumonia in children: what's old? What's new?

Massimiliano Don et al.

ACTA PAEDIATRICA (2010)

Add to Collection

Editorial Material Medicine, General & Internal

GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations

Gordon H. Guyatt et al.

BRITISH MEDICAL JOURNAL (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.